National Institute on Minority Health and Health Disparities; Notice of Closed Meeting, 7402-7403 [2024-02087]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
7402
Federal Register / Vol. 89, No. 23 / Friday, February 2, 2024 / Notices
Agenda: To review and evaluate grant
applications.
Place: North Bethesda Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Zarana Patel, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–9295, zarana.patel@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Cell Biology, Developmental
Biology, and Bioengineering.
Date: February 29–March 1, 2024.
Time: 8:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Mufeng Li, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–5653, limuf@nih.gov.
Name of Committee: Infectious Diseases
and Immunology A Integrated Review Group;
Cellular and Molecular Immunology—B
Study Section.
Date: February 29–March 1, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Liying Guo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, (301) 827–
7728, lguo@mail.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Organization and Delivery of Health Services
Study Section.
Date: February 29–March 1, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Catherine Hadeler
Maulsby, MPH, Ph.D., Scientific Review
Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 435–1266,
maulsbych@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Biophysical, Physiological,
Pharmacological and Bioengineering
Neuroscience, and Vision.
Date: February 29–March 1, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Jennifer Kielczewski,
Ph.D., Scientific Review Officer, Center for
VerDate Sep<11>2014
17:08 Feb 01, 2024
Jkt 262001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1042, jennifer.kielczewski@
nih.gov.
Name of Committee: Applied Immunology
and Disease Control Integrated Review
Group; Vaccines Against Infectious Diseases
Study Section.
Date: February 29–March 1, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Jian Wang, Ph.D., MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
MSC 7812, Bethesda, MD 20892, (301) 213–
9853, wangjia@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Therapeutic Immune Regulation
Study Section.
Date: February 29–March 1, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Yue Wu, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 803C, Bethesda, MD 20892,
(301) 867–5309, wuy25@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Etiology, Diagnostic, Intervention and
Treatment of Infectious Diseases Study
Section.
Date: February 29–March 1, 2024.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Liangbiao Zheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
MSC 7808, Bethesda, MD 20892, (301) 996–
5819, zhengli@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Maximizing
Investigators’ Research Award C Study
Section.
Date: February 29–March 1, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8559, jimok.kim@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Genes, Genomes and Genetics.
Date: February 29–March 1, 2024.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Linda Wagner Jurata,
Scientific Review Officer, The Center for
Scientific Review, The National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–8032, linda.jurata@nih.gov.
Name of Committee: Infectious Diseases
and Immunology A Integrated Review Group;
Innate Immunity and Inflammation Study
Section.
Date: February 29–March 1, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Bakary Drammeh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 805–P,
Bethesda, MD 20892, (301) 435–0000,
drammehbs@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 29, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–02047 Filed 2–1–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Interventions to
Address HIV-Related Comorbidities among
E:\FR\FM\02FEN1.SGM
02FEN1
Federal Register / Vol. 89, No. 23 / Friday, February 2, 2024 / Notices
Highly Affected Populations Experiencing
Health Disparities.
Date: March 21, 2024.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIMHD DEM II, Suite 800, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Ivan K. Navarro, Ph.D.,
Scientific Review Officer, Office of
Extramural Research Administration,
National Institute on Minority Health and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892, 301–827–2061,
ivan.navarro@nih.gov.
Dated: January 30, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–02087 Filed 2–1–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; AD/ADRD
Research—Renewal and Competing Revision
Cooperative Agreements.
Date: February 29, 2024.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sandhya Sanghi, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, 7201
Wisconsin Avenue, Gateway Bldg., Suite
2N230, (301) 496–2879, sandhya.sanghi@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
VerDate Sep<11>2014
17:08 Feb 01, 2024
Jkt 262001
7403
Dated: January 30, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: January 29, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–02122 Filed 2–1–24; 8:45 am]
[FR Doc. 2024–02050 Filed 2–1–24; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Clinical and Data
Coordinating Center Applications for NCCIH
Multi-Site Clinical Trials of Mind and Body
Interventions.
Date: March 1, 2024.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
National Center for Complementary and
Integrative Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual).
Contact Person: Baila S. Hall, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
National Center for Complementary and
Integrative Health, National Institutes of
Health, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 443–9285,
baila.hall@nih.gov.
Marta V. Hamity, Ph.D., Scientific Review
Officer, Office of Scientific Review, Division
of Extramural Activities, National Center for
Complementary and Integrative Health,
National Institutes of Health, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892, marta.hamity@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Precision Mental Health: Develop Tools to
Inform Treatment Selection in Depression
(UG3/UH3).
Date: February 29, 2024.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Jasenka Borzan, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Blvd., Neuroscience Center,
Bethesda, MD 20892, (301) 435–1260,
jasenka.borzan@nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; AMP
SCZ: Clinical High Risk for Psychosis
Clinical Trial Network and DPACC (U01 &
U24).
Date: February 29, 2024.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Bethesda, MD 20892–9608, 301–443–4525,
steinerr@mail.nih.gov.
E:\FR\FM\02FEN1.SGM
02FEN1
]]>Agencies
[Federal Register Volume 89, Number 23 (Friday, February 2, 2024)]
[Notices]
[Pages 7402-7403]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02087]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health and Health Disparities;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Minority Health and
Health Disparities Special Emphasis Panel; Interventions to Address
HIV-Related Comorbidities among
[[Page 7403]]
Highly Affected Populations Experiencing Health Disparities.
Date: March 21, 2024.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, NIMHD DEM II, Suite 800,
6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ivan K. Navarro, Ph.D., Scientific Review
Officer, Office of Extramural Research Administration, National
Institute on Minority Health and Health Disparities, National
Institutes of Health, 6707 Democracy Blvd., Suite 800, Bethesda, MD
20892, 301-827-2061, [email protected].
Dated: January 30, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02087 Filed 2-1-24; 8:45 am]
BILLING CODE 4140-01-P
